The siRNA-mediated knockdown of human gastric adenocarcinoma AGS cells was shown to be successful by qPCR analysis in that the levels of HER3 were substantially lower in cells treated with anti-HER3 siRNA compared to siRNA control (Fig 1). This evidence concerns the gene ERBB3 and gastric adenocarcinoma.